Afficher la notice abrégée

dc.contributor.advisorEpstein, David Mark 
dc.contributor.advisorEspín Balbino, Jaime
dc.contributor.authorRejón Parrilla, Juan Carlos
dc.contributor.otherUniversidad de Granada. Programa de Doctorado en Ciencias Económicas y Empresarialeses_ES
dc.date.accessioned2024-06-04T10:45:58Z
dc.date.available2024-06-04T10:45:58Z
dc.date.issued2024
dc.date.submitted2024-04-04
dc.identifier.citationRejón Parrilla, Juan Carlos. The value and measurement of innovation in health technology assessment and its impact on public financing of medicines. Granada: Universidad de Granada, 2024. [https://hdl.handle.net/10481/92318]es_ES
dc.identifier.isbn9788411952972
dc.identifier.urihttps://hdl.handle.net/10481/92318
dc.description.sponsorshipTesis Univ. Granada.es_ES
dc.description.sponsorshipChapters I, II and III of this PhD thesis received support from the CEAT project (research project PID2019.105597RA.I00 financed by the Spanish Ministry of Science and Innovation/ National Research Agency MCIN/ AEI/10.13039/501100011033). The funders had no role in the study.es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoenges_ES
dc.publisherUniversidad de Granadaes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleThe value and measurement of innovation in health technology assessment and its impact on public financing of medicineses_ES
dc.typedoctoral thesises_ES
europeana.typeTEXTen_US
europeana.dataProviderUniversidad de Granada. España.es_ES
europeana.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/en_US
dc.rights.accessRightsopen accesses_ES
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

  • Tesis
    Tesis leídas en la Universidad de Granada

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional